Posted Jul. 17, 2012 at 2:24 p.m.

Premium Lock GSK's $3.6B hostile takeover of HGS could pay handsome dividends

Published: 2012-07-17 14:24:56
Updated: 2012-07-17 14:24:56


Buying Human Genome gives Glaxo full control over marketing Benlysta, which won U.S. approval last year as the first new lupus drug in five decades. Glaxo and Human Genome are also collaborating on two experimental medicines that are in late-stage testing: albiglutide for diabetes and darapladib for heart disease....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders